Search Filters

Search Results

Found 3 results

510(k) Data Aggregation

    K Number
    K251717
    Date Cleared
    2025-06-26

    (22 days)

    Product Code
    Regulation Number
    888.3560
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Freedom**®** Total Knee System – Titanium Tibial Base Plate

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Freedom® Total Knee System is indicated for the following:

    • Severe knee joint pain, loss of mobility, and disability due to: rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis.
    • Correction of functional deformities.
    • Post-traumatic loss of knee joint contour, particularly when there is patellofemoral erosion, dysfunction, or prior patellectomy.
    • Moderate valgus, varus, or flexion trauma.
    • Knee fractures untreatable by other methods.
    • Revision surgery where sufficient bone stock and soft tissue integrity are present (For PCK Components and Primary PCK Components only).

    The Freedom® Total Knee System – Titanium Tibial Base Plate is intended for cemented and single use only.

    Device Description

    The Freedom® Total Knee System is comprised of a femoral component, all-poly tibial component, patellar component, tibial base plate and tibial articular surface. The Freedom® Total Knee System's Femoral Component is offered as different versions such as stemmed PCK design, primary PCK, cruciate retaining, posterior stabilizing. The Freedom® Total Knee System's Tibial Base Plate is offered with stemmed design and without stemmed design. The Freedom® Total Knee System was originally cleared under the 510(k) number K082019. Later on, several modifications were made and were cleared under 510(k)s K091280, K192148, K090411, K182574, K131481, K111785 and K200912 respectively.

    The primary purpose of this special 510(k) Device Modification to the Freedom® Metal Backed Tibial Component (K090411) is to notify the FDA of the change in materials used to manufacture the tibial base plate from CoCrMo to Wrought Titanium-6Aluminium-4Vanadium ELI Alloy (Ti6Al4V ELI, ASTM F136-13) as an alternative material option for the tibial base plate.

    The Titanium Tibial Base Plate is fabricated from Titanium alloy Ti-6Al-4V ELI, compliant with ASTM F136 and is intended for cemented application to replace the articulating surface of the proximal tibia in a measured resection technique.

    The Titanium Tibial Base Plates are available in 8 different sizes (1 to 8) based on Anterior/Posterior (A/P) and Medial/Lateral (M/L) dimensions.

    AI/ML Overview

    This 510(k) clearance letter pertains to a Class II medical device, specifically the Freedom® Total Knee System - Titanium Tibial Base Plate (K251717). The submission is a special 510(k) Device Modification, indicating that the changes made to the device are well-defined and do not significantly alter the indications for use or raise new questions of safety and effectiveness.

    The core change is the material of construction for the tibial base plate, shifting from CoCrMo to Wrought Titanium-6Aluminium-4Vanadium ELI Alloy (Ti-6Al-4V ELI). The design, geometry, surfaces, and locking features remain identical to the previously cleared predicate device (K090411).

    Therefore, the acceptance criteria and the study proving the device meets these criteria primarily focus on mechanical performance and biocompatibility related to this material change, rather than extensive clinical efficacy studies or comparative effectiveness studies involving human readers, as would be typical for AI/software devices.


    Acceptance Criteria and Reported Device Performance

    Given the nature of this submission (a material change for an orthopedic implant with identical design), the acceptance criteria are not explicitly numerical thresholds like sensitivity/specificity, but rather involve demonstrating mechanical equivalence to the predicate device and biocompatibility of the new material.

    Here's a table summarizing the implicit acceptance criteria based on standard regulatory requirements for such a device modification, and how the document indicates they were met:

    Acceptance Criteria CategorySpecific Criteria (Implicit from Submission Type)Reported Device Performance (as per 510(k) Summary)
    Mechanical PerformanceThe Titanium Tibial Base Plate must demonstrate equivalent or superior mechanical integrity and fatigue resistance compared to the predicate device to ensure durability and prevent failure under intended physiological loads.Met. "The design, geometry, surface features, locking features and dimensional attributes of the Titanium Tibial Base Plate are identical to those of the previously cleared Freedom® Metal Backed Tibial Base Plate (K090411)."
    "Hence, to evaluate the device function and performance for its intended use, the Freedom® Titanium Tibial Base Plate was subjected to the following mechanical tests:Tibial Tray Fatigue Testing per ASTM F1800Range of Motion & Modular disassembly testing was leveraged from the reference device (K090411) as the subject device uses an identical tibial insert locking mechanism."
    Material BiocompatibilityThe new material (Ti-6Al-4V ELI) must be biocompatible and not elicit adverse biological responses (e.g., toxicity, sensitization, irritation) when implanted in the human body.Met. "Biocompatibility testing is not required for the subject Titanium Tibial Base Plate device, because the material, Ti-6Al-4V ELI Titanium Alloy is compliant with ASTM F136, is a well-established material with a long history of safe use in orthopedic implants."
    "This material has been used extensively for many years without any major biocompatibility related safety concerns."
    "Additionally, the material has been used in multiple components of Maxx Orthopedics' previously cleared Freedom® Total Knee System…"
    "It also complies with the biocompatibility requirements outlined in 'Class II Special Controls Guidance Document: Knee Joint Patellofemorotibial and Femorotibial Metal/Polymer Porous-Coated Uncemented Prostheses; Guidance for Industry and FDA'".
    "Furthermore, Ti-6Al-4V ELI Titanium Alloy (ASTM F136) has also been used in similar tibial base plate components from other legally marketed devices, intended for same anatomical location and patient contact type, as demonstrated in K220737."
    "A risk-based assessment, following the principles outlined in FDA's 2023 Biocompatibility guidance (Use of ISO 10993-1), confirms that the material change does not introduce new types of patient contact, contact duration, or clinical use conditions that would require additional biocompatibility testing."
    Equivalence in Design/FunctionThe device design must be substantially equivalent to the predicate, with any minor differences not raising new safety or effectiveness concerns.Met. "The design, geometry, surface features, locking features and dimensional attributes of the Titanium Tibial Base Plate are identical to those of the previously cleared Freedom® Metal Backed Tibial Base Plate (K090411)."
    "There are no significant technological differences between the subject and predicate device. The subject device uses a similar design and dimensions, geometry and sizing, and achieves its intended use in an identical manner as the primary predicate and both devices are manufactured using similar subtractive manufacturing techniques."
    Sterilization Method (Minor Change)If the sterilization method changes, its effectiveness must be validated.Addressed. "Minor differences in subject device are that it uses different materials of constructions and sterilization method that are addressed via performance testing and similarity to the secondary predicate devices (K241597)." While not explicitly detailed, the mention implies this was covered.

    Study Details (Relevant to Orthopedic Implants, Not AI)

    The provided text describes a submission for an orthopedic implant and does not involve an AI/software component, nor does it detail a clinical study with human patients for AI performance evaluation. Therefore, many of the requested points regarding sample sizes for test/training sets, expert readers, ground truth for AI, MRMC studies, etc., are not applicable to this type of device clearance and are consequently not found in the document.

    However, based on the information provided, here's what can be inferred/stated:

    1. Sample size used for the test set and data provenance:

      • Test Set: Not applicable in the context of clinical AI performance data. For mechanical testing (ASTM F1800), standard test methods specify the number of samples required (e.g., minimum of 6 samples for fatigue per ASTM F1800-97), but the exact number used in this specific submission is not reported in the summary.
      • Data Provenance: Not applicable for AI performance data. For material and design, the device is manufactured by Maxx Orthopedics Inc. (Norristown, PA, USA) and Meril Healthcare Pvt. Ltd. (Vapi, Gujarat, India).
    2. Number of experts used to establish the ground truth for the test set and qualifications of those experts:

      • Not applicable as this is a mechanical and material modification, not an AI diagnostic device requiring expert interpretation of images for ground truth.
    3. Adjudication method (e.g., 2+1, 3+1, none) for the test set:

      • Not applicable for the type of device/study described.
    4. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

      • No. This type of study (MRMC, AI assistance) is not relevant or performed for this device. The submission is for a physical orthopedic implant with a material change.
    5. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

      • Not applicable, as there is no algorithm or AI component in this device.
    6. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

      • For the mechanical testing, the "ground truth" would be the engineering specifications and performance of the predicate device, alongside adherence to international standards (e.g., ASTM F1800).
      • For biocompatibility, the "ground truth" is established long-term clinical use data, compliance with ASTM F136 (Standard Specification for Wrought Titanium-6Aluminum-4Vanadium ELI Alloy for Surgical Implant Applications), and prior FDA clearances of devices using this material.
    7. The sample size for the training set:

      • Not applicable (no AI training set).
    8. How the ground truth for the training set was established:

      • Not applicable (no AI training set).

    In summary, the FDA clearance for K251717 as a special 510(k) is based on demonstrating that the new Titanium Tibial Base Plate is mechanically equivalent to its predicate and that the new material is biocompatible and has a well-established history of safe use in similar orthopedic applications. The regulatory review focuses on engineering performance criteria and material biocompatibility rather than clinical performance data from patient studies or AI algorithm validation.

    Ask a Question

    Ask a specific question about this device

    K Number
    K241597
    Date Cleared
    2025-02-13

    (255 days)

    Product Code
    Regulation Number
    888.3565
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Freedom**®** Total Knee System - Porous Tibial Base Plate

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Freedom® Total Knee System is indicated for the following:
    • Severe knee joint pain, loss of mobility, and disability due to: rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis.
    • Correction of functional deformities.
    • Post-traumatic loss of knee joint contour, particularly when there is patellofemoral erosion, dysfunction, or prior patellectomy.
    • Moderate valgus, varus, or flexion trauma.
    • Knee fractures untreatable by other methods.
    • Revision surgery where sufficient bone stock and soft tissue integrity are present (For PCK Components and Primary PCK Components only).
    The Freedom® Porous Tibial Base Plate and Cementless Femoral Components are indicated for Cemented or Uncemented use. All other components are indicated for cemented use only.

    Device Description

    The Freedom® Porous Tibial Base Plate is a line extension of the Freedom® Total Knee System comprising of tibial base plate components for cemented or uncemented use in total knee arthroplasty. Freedom® Porous Tibial Base Plates are intended for use with existing, compatible Freedom® femoral and tibial liner components. Freedom® Porous Tibial Base Plates are additively manufactured from Ti-6Al-4V ELI Grade 23 and include a porous lattice structure on the distal face. Freedom® Porous Tibial Base Plates are available in eight asymmetric design offerings (Sizes 1 – 8, Left / Right configurations), based on anterior / posterior (A/P) and medial / lateral (M/L) dimensions.

    AI/ML Overview

    The provided document is a 510(k) premarket notification for a medical device, specifically the Freedom® Total Knee System - Porous Tibial Base Plate. This type of regulatory submission focuses on demonstrating substantial equivalence to a legally marketed predicate device rather than undergoing a de novo clinical study with strict acceptance criteria and performance analysis. Therefore, the information requested about acceptance criteria and a study proving the device meets them, typically found in a clinical trial report or a performance study for novel devices or software, is not directly applicable in the same way.

    However, I can extract the information related to the non-clinical performance testing conducted to support the substantial equivalence claim. This testing serves as the "study" demonstrating that the device performs as intended and is similar to the predicate.

    Here's an interpretation based on the provided text:

    1. A table of acceptance criteria and the reported device performance

    The document does not explicitly state numerical "acceptance criteria" for each test in the way a clinical trial might. Instead, the "acceptance" is implicitly defined by demonstrating that the subject device's performance is substantially equivalent to established performance standards or the predicate/reference devices. The "reported device performance" is summarized as the satisfactory completion of these tests.

    Acceptance Criteria (Implicit)Reported Device Performance
    Tibial Tray Fatigue: Device must withstand fatigue loading per ASTM F1800.All necessary testing performed. (Implies satisfactory performance meeting the standard).
    Residual Particle Characterization: Device must meet acceptable levels of residual particles per ASTM F1877, comparable to literature.Results were shown to be substantially equivalent to values presented in the literature for the reference device (K030623).
    Porous Surface Characterization: Porous structure must meet specifications for various characteristics per ASTM F1854, F1160, F1044, F1978, F1147.All necessary testing performed. (Implies satisfactory performance meeting the standards).
    Sterilization: Device must achieve a sterility assurance level (SAL) of 10^-6 per ISO 11137-2.Sterilization per ISO 11137-2. (Implies successful sterilization to the required SAL).
    Endotoxin: Device must meet acceptable endotoxin levels per AAMI ST72.Endotoxin per AAMI ST72. (Implies acceptable endotoxin levels).
    Biocompatibility: Device materials must be biocompatible per ISO 10993-1, ISO 10993-5.Biocompatibility per ISO 10993-1, ISO 10993-5. (Implies successful demonstration of biocompatibility).
    Modular Disassembly: If applicable, modular components must meet disassembly force requirements (leveraged from reference device).Modular disassembly testing was leveraged from the reference device (K090411) as the subject device uses an identical tibial insert locking mechanism. (Implies that the design similarity ensures equivalent performance without new testing).

    2. Sample sized used for the test set and the data provenance

    • Sample Size: The document does not specify the exact number of implants or test coupons used for each non-clinical test (e.g., how many tibial trays were fatigue tested). It mentions that "All testing was performed on worst case implants or test coupons as dictated by the relevant performance standards."
    • Data Provenance: The tests are non-clinical (laboratory/mechanical testing), not human clinical data. Thus, terms like "country of origin" or "retrospective/prospective" are not applicable. The data originates from laboratory testing conducted by or for the manufacturer (Maxx Orthopedics, Inc.).

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    This information is not applicable. The "test set" here refers to physical specimens (implants/coupons) for non-clinical testing, not patient data requiring expert interpretation or ground truth establishment. The "ground truth" for these tests is defined by the technical specifications and requirements of the referenced ASTM and ISO standards.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    This is not applicable as the tests are non-clinical, mechanical, and material evaluations performed against established standards, not clinical data requiring adjudication by experts.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    This is not applicable. The device is a physical knee implant, not an AI software or diagnostic tool used by human readers.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    This is not applicable. The device is a physical knee implant, not an algorithm.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    For the non-clinical performance tests, the "ground truth" is defined by the technical specifications and requirements outlined in the referenced ASTM and ISO standards. For example, the acceptable number of cycles for fatigue testing is defined by ASTM F1800. For residual particles, the "ground truth" is the acceptable range established in the literature for the reference device, as evaluated against ASTM F1877.

    8. The sample size for the training set

    This is not applicable. The device is a physical knee implant. There is no "training set" in the context of machine learning or AI. The manufacturing process is validated, and the device's design is based on engineering principles and existing predicate designs, not a data-driven training set.

    9. How the ground truth for the training set was established

    This is not applicable for the reasons stated above.

    Ask a Question

    Ask a specific question about this device

    K Number
    K240863
    Date Cleared
    2024-07-02

    (96 days)

    Product Code
    Regulation Number
    888.3560
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Freedom**®** Total Knee System

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Freedom® Total Knee System is indicated for patients with severe knee pain and the disability due to:

    · Severe knee joint pain, loss of mobility, and disability due to: rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis.

    · Correction of functional deformities.

    • · Post-traumatic loss of knee joint contour, particularly when there is patellofemoral erosion,
      dysfunction, or prior patellectomy.

    • · Moderate valgus, varus, or flexion trauma.

    • · Knee fractures untreatable by other methods.

    · Revision surgery where sufficient bone stock and soft tissue integrity are present.

    The Freedom® Total Knee System is intended for cemented and for single use only.

    Device Description

    The Freedom® Total Knee System is comprised of a femoral component, all-poly tibial component, patellar component, tibial base plate and tibial articular surface. The Freedom® Total Knee System's Femoral Component is offered as different versions such as stemmed PCK design, primary PCK, cruciate retaining, posterior stabilizing. The Freedom® Total Knee System's Tibial Base Plate is offered with stemmed design and without stemmed design.

    This submission seeks the clearance of Titanium Nitride (TiNbN) coated version of previously cleared Stemmed PCK Femoral Component (non-coated version cleared in K131481) and Stemmed Tibial Base Plate (non-coated version cleated in K111785). The coated versions are now branded as Titan PCK Stemmed Femoral Component and Titan Stemmed Tibial Base Plate.

    Both these components are manufactured from CoCrMo alloy and are coated completely with Titanium Niobium Nitride (TiNbN).

    AI/ML Overview

    This document is a 510(k) premarket notification for a medical device, the Freedom® Total Knee System, and does not contain information about the development or testing of an AI/ML powered medical device. Therefore, I cannot extract the requested information regarding acceptance criteria or a study proving an AI/ML device meets those criteria.

    The document discusses the substantial equivalence of a new version of a total knee system (with a TiNbN coating) to previously cleared versions. The "performance testing" section refers to mechanical and biocompatibility tests for the physical knee implant components and their coating, not the performance of a software or algorithm. There is no mention of AI, machine learning, or any related technology.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1